Date Name Title Type Shares Traded Price
Dec 14, 2010
Director, EVP CSO & Pres Regn Res Labs
Director, EVP CSO & Pres Regn Res Labs Grant, award or other acquisition pursuant to Rule 16b-3(d) 3,264 --
Dec 14, 2010
Director, EVP CSO & Pres Regn Res Labs
Director, EVP CSO & Pres Regn Res Labs Grant, award or other acquisition pursuant to Rule 16b-3(d) 96,736 --
Dec 14, 2010
Director, EVP CSO & Pres Regn Res Labs
Director, EVP CSO & Pres Regn Res Labs Grant, award or other acquisition pursuant to Rule 16b-3(d) 250,000 --
Dec 18, 2009
Director, EVP CSO & Pres Regn Res Labs
Director, EVP CSO & Pres Regn Res Labs Grant, award or other acquisition pursuant to Rule 16b-3(d) 4,705 --
Dec 18, 2009
Director, EVP CSO & Pres Regn Res Labs
Director, EVP CSO & Pres Regn Res Labs Grant, award or other acquisition pursuant to Rule 16b-3(d) 95,295 --
Dec 07, 2009
Director, EVP CSO & Pres Regn Res Labs
Director, EVP CSO & Pres Regn Res Labs Other acquisition or disposition -- --
Dec 03, 2009
Director, EVP CSO & Pres Regn Res Labs
Director, EVP CSO & Pres Regn Res Labs Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 100,000 $8.77
Dec 03, 2009
Director, EVP CSO & Pres Regn Res Labs
Director, EVP CSO & Pres Regn Res Labs Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 45,463 $19.29
Dec 03, 2009
Director, EVP CSO & Pres Regn Res Labs
Director, EVP CSO & Pres Regn Res Labs Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 22,397 $19.29
Dec 03, 2009
Director, EVP CSO & Pres Regn Res Labs
Director, EVP CSO & Pres Regn Res Labs Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 100,000 --

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.